Head and neck disease
Conditions
Sponsors
Eye & ENT Hospital of Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Age 18 to 75 years (inclusive of ages 18 and 75); 2) Gender: No restrictions; 3) Patients who meet the indications for minimally invasive surgery in pharyngeal and head and neck surgery, requiring TORS minimally invasive surgical treatment, such as those diagnosed with benign; pharyngeal and laryngeal tumors, T1-T2 stage and some T3 stage oropharyngeal cancer, laryngeal cancer, hypopharyngeal cancer, etc.; 4) Voluntarily participate in this trial and sign a written informed consent form.
Exclusion criteria
Exclusion criteria: 1) Patients with limited mouth opening; 2) Patients with neck lymph node metastases that are not amenable to surgical clearance; 3) Patients whose overall condition cannot tolerate general anesthesia; 4) Lymph node metastases that are fused and encasing major blood vessels; 5) Tumors with extensive infiltration into surrounding tissues, making minimally invasive surgery inappropriate; 6) Patients with poor overall condition that cannot be corrected despite preoperative treatment; 7) Patients with severe cardiac, pulmonary, hepatic, or renal diseases who cannot tolerate surgery; 8) Patients requiring emergency surgery due to disease conditions; 9) Patients who have been treated with systemic corticosteroids or immunosuppressants continuously in the past month; 10) Patients who are mentally incapable or unable to understand the requirements of participation in the study; 11) Pregnant or breastfeeding women; 12) Patients unwilling or unable to comply with medical advice; 13) Patients who have participated in another clinical trial within the past month; 14) Other conditions deemed inappropriate for inclusion by the researchers and medical staff.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary efficacy endpoint evaluation;Pain scores;Vital signs (body temperature, breathing, pulse, blood pressure);Physical examination; | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of equipment performance;Equipment defects;Tumor biomarkers;Physical status score; | — |
Countries
China
Contacts
Public ContactLei Tao
Eye & ENT Hospital of Fudan University
Outcome results
None listed